Clinically Significant Genetic Results in Fetuses With Isolated Horseshoe Kidney
Qiu-Xia Yu1, Yu-Tong Ni1, Yong-Ling Zhang1
1Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
Prenatal Diagnosis
|February 16, 2026
Summary
Genetic testing for isolated fetal horseshoe kidney (HSK) identified copy number variants (CNVs) in 3.2% and monogenic conditions in 4.4% of cases. These findings support the use of genetic investigation in pregnancies with isolated fetal HSK.
Area of Science:
- Medical Genetics
- Prenatal Diagnosis
- Urology
Background:
- Isolated horseshoe kidney (HSK) is a congenital anomaly with potential genetic underpinnings.
- Prenatal diagnosis of isolated HSK necessitates further investigation into underlying genetic causes.
Purpose of the Study:
- To evaluate the diagnostic yield of genetic testing in fetuses diagnosed with isolated horseshoe kidney (HSK).
Main Methods:
- Retrospective analysis of 95 cases with isolated fetal HSK diagnosed via second-trimester ultrasound.
- Invasive prenatal diagnosis using chromosomal microarray analysis (CMA) for copy number variant (CNV) detection.
- Trio exome sequencing (ES) offered for cases with negative CNV results.
Main Results:
- Chromosomal microarray analysis (CMA) detected pathogenic CNVs in 3.2% of cases (1 isochromosome X, 1 duplication 16p13.11, 1 deletion 7q11.22).
- Trio exome sequencing (ES) in 45 cases identified disease-causing variants in PSMD12 and KMT2D, yielding a 4.4% diagnostic rate for monogenic conditions.
- Combined genetic testing yielded a significant diagnostic rate for underlying genetic abnormalities.
Conclusions:
- Genetic investigation, including CMA and ES, offers a valuable diagnostic yield in fetuses with isolated HSK.
- The findings support the recommendation for genetic testing in pregnancies complicated by isolated fetal HSK.
- Identifying genetic causes can inform genetic counseling and management strategies.
More Related Videos
Related Concept Videos
Teratogenicity
4.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Pleiotropy
43.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.4K
Genetic Lingo
115.4K
Overview
115.4K


